Gene Expression Profiles of Treatment Response and Non-Response in Children With Juvenile Dermatomyositis

Cory Stingl, Jeffrey A. Dvergsten, Simon W.M. Eng, Rae S.M. Yeung, Marvin J. Fritzler, Thomas Mason, Cynthia Crowson, Deepak Voora, Ann M Reed

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The study objective was to identify differences in gene expression between treatment responders (TRs) and treatment non-responders (TNRs) diagnosed with juvenile dermatomyositis (JDM). Methods: Gene expression analyses were performed using whole blood messenger RNA sequencing in patients with JDM (n = 17) and healthy controls (HCs; n = 10). Four analyses were performed (A1-4) comparing differential gene expression and pathways analysis exploiting the timing of sample acquisition and the treatments received to perform these comparative analyses. Analyses were done at diagnosis and follow-up, which averaged 7 months later in the cohort. Results: At diagnosis, the expression of 10 genes differed between TRs and TNRs. Hallmark and canonical pathway analysis revealed 11 and 60 pathways enriched in TRs and 3 and 21 pathways enriched in TNRs, respectively. Pathway enrichment at diagnosis in TRs was strongest in pathways involved in metabolism, complement activation, and cell signaling as mediated by IL-8, p38/microtubule associated protein kinases (MAPK)/extracellular signal-regulated kinases (ERK), Phosphatidylinositol 3 Kinase Gamma (PI3Kγ), and the B cell receptor. Follow-up hallmark and canonical pathway analysis showed that 2 and 14 pathways were enriched in TRs, whereas 24 and 123 pathways were enriched in treatment TNRs, respectively. Prior treatment with glucocorticoids significantly altered expression of 13 genes in the analysis of subjects at diagnosis with JDM as compared with HCs. Conclusion: Numerous genes and pathways differ between TRs and TNRs at diagnosis and follow-up. Prior treatment with glucocorticoids prior to specimen acquisition had a small effect on the performed analyses.

Original languageEnglish (US)
Pages (from-to)671-681
Number of pages11
JournalACR Open Rheumatology
Volume4
Issue number8
DOIs
StatePublished - Aug 2022

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'Gene Expression Profiles of Treatment Response and Non-Response in Children With Juvenile Dermatomyositis'. Together they form a unique fingerprint.

Cite this